David Dorman - CVS Health Independent Chairman of the Board

CVS Stock  USD 77.57  0.17  0.22%   

Chairman

Mr. David W. Dorman is Independent Chairman of the Board of CVS Caremark Corporationration Mr. Dorman was the Chairman of the Board of CVS Health Corporation since May 2011. He has also been a Founding Partner of Centerview Capital Technology Fund, a private investment firm, since July 2013. He also served as Lead Director of Motorola Solutions, Inc., a communications products company, until his retirement from that board in May 2015, and was NonExecutive Chairman of the Board of Motorola from May 2008 through May 2011. From October 2006 through April 2008, he was a Managing Director and Senior Advisor with Warburg Pincus LLC, a global private equity firm. From November 2005 until January 2006, Mr. Dorman served as President and a director of ATT Inc., a telecommunications company . From November 2002 until November 2005, Mr. Dorman was Chairman of the Board and Chief Executive Officer of ATT Corporation since 2011.
Age 66
Tenure 13 years
Address One CVS Drive, Woonsocket, RI, United States, 02895
Phone401 765 1500
Webhttps://www.cvshealth.com
Dorman is also a director of PayPal Holdings, Inc., a leading digital and mobile payments company, as well as Dell Technologies Inc., the world’s largest privately controlled technology company. He was also a director of SecureWorks Corporationrationration, an information security solutions provider and a subsidiary of Dell, from the time of SecureWorks’ IPO in April 2016 until he joined the board of Dell in September 2016. He was a director of Yum! Brands, Inc., a global quick service restaurant company, from 2005 until his retirement from that board in May 2017. B.S., Georgia Institute of Technology.

CVS Health Management Efficiency

The company has Return on Asset of 0.0368 % which means that on every $100 spent on assets, it made $0.0368 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1128 %, implying that it generated $0.1128 on every 100 dollars invested. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 79.39 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. CVS Health Corp has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist CVS Health until it has trouble settling it off, either with new capital or with free cash flow. So, CVS Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CVS Health Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CVS to invest in growth at high rates of return. When we think about CVS Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CHAIRMAN Age

Gordon RitterVeeva Systems Class
55
Michael MussallemEdwards Lifesciences Corp
71
CVS Health Corporation provides health services in the United States. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 216000 people. CVS Health Corp (CVS) is traded on New York Stock Exchange in USA. It is located in One CVS Drive, Woonsocket, RI, United States, 02895 and employs 219,000 people. CVS Health is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

CVS Health Corp Leadership Team

Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
J Joyner, Executive Vice President
Shawn Guertin, Chief Financial Officer, Executive Vice President
Richard Bracken, Independent Director
Mary Schapiro, Independent Director
Laurence McGrath, Senior Relations
Norman Greve, Chief Officer
David Brown, Independent Director
William Weldon, Independent Director
Kevin Hourican, Executive Vice President, President of CVS Pharmacy
Larry McGrath, Sr Relations
Stephen Gold, Senior Vice President CIO
Joshua Flum, Executive Vice President, Chief Strategy and Business Development Officer
Troyen Brennan, Executive Vice President Chief Medical Officer
Prem Shah, Executive Vice President, Chief Pharmacy Officer and Co-President of Retail
Karen Lynch, President, Chief Executive Officer, Director
Thomas Moriarty, Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
Per Lofberg, Executive Vice President
David Joyner, Executive Vice President
David Falkowski, Executive Officer
Prem PharmD, Chief VP
Jonathan Roberts, Chief Operating Officer, Executive Vice President
Alan Lotvin, Executive Vice President and Presidentident - CVS Caremark
Neela Montgomery, Executive Vice President and President - CVS Pharmacy/Retail
Alan MD, Ex Services
Andrew Sussman, Senior Vice President Associate Chief Medical Officer
Robert Kraft, Executive Vice President
Edward Ludwig, Independent Director
David Dorman, Independent Chairman of the Board
Richard Swift, Independent Director
Fernando Aguirre, Independent Director
Laurie Havanec, Chief People Officer, Executive Vice President
C Brown, Independent Director
NancyAnn DeParle, Independent Director
David CEBS, Executive Caremark
Tilak Mandadi, Data, Digital
Thomas Cowhey, Executive CFO
JeanPierre Millon, Independent Director
Mark Bertolini, Independent Director
Alecia DeCoudreaux, Independent Director
Samrat Esq, Chief VP
Lisa Bisaccia, Chief Human Resource Officer, Executive Vice President
David Denton, CFO and Executive VP
Helena Foulkes, Executive VP and President of CVS Pharmacy Inc
Tony White, Independent Director
Anne Finucane, Independent Director
Vijay Patel, Senior CoFounder
Derica Rice, Executive Vice President, President of CVS Caremark
James Clark, Senior Vice President - Controller, Chief Accounting Officer
Eva Boratto, Chief Financial Officer, Executive Vice President
Daniel Finke, Executive Vice President and Presidentident - Health Care Benefits Segment
Larry Merlo, President, Chief Executive Officer, Director
Roger Farah, Independent Director
Michelle Peluso, Executive Vice President, Chief Customer Officer and Co-President of Retail

CVS Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with CVS Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CVS Health Corp is a strong investment it is important to analyze CVS Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CVS Health's future performance. For an informed investment choice regarding CVS Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for CVS Stock analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.10)
Dividend Share
2.42
Earnings Share
6.47
Revenue Per Share
277.528
Quarterly Revenue Growth
0.12
The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if CVS Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.